Point-of-Care Coagulation Monitoring in Trauma Patients

Seminars in Thrombosis and Hemostasis

Volumn 43, Issue 4, 2017, Pages 367-374

  Stein, Philipp ^a   Kaserer, Alexander ^a   Spahn, Gabriela H ^a   Spahn, Donat R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

coagulation management; goal directed algorithm; point of care; trauma induced coagulopathy

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTAMINE SULFATE; TRANEXAMIC ACID;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; CLINICAL OUTCOME; COAGULOMETER; CRYSTALLOID; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HUMAN; INJURY; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPH; VISCOELASTICITY; BLOOD; BLOOD CLOTTING TEST; COMPLICATION; POINT OF CARE SYSTEM; PROCEDURES;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; HUMANS; POINT-OF-CARE SYSTEMS; POINT-OF-CARE TESTING; WOUNDS AND INJURIES;

EID: 85015681061     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0037-1598062     Document Type: Article

References (81)

1. World Health Organization. Violence and Injury Prevention. Available at: http://who.int/violence-injury-prevention/en/. Accessed September 20,: 2016
2. Rossaint R. Bouillon B. Cerny V., et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care: 2016; 20 100
3. Shapiro D. S. Umer A. Marshall W. T., et al. Use of a Modified American College of Surgeons Trauma Quality Improvement Program to Enhance 30-Day Post-Trauma Readmission Detection. J Am Coll Surg: 2016; 222 05 865 869
4. Moore L. Evans D. Hameed S. M., et al. Mortality in Canadian Trauma Systems: a multicenter cohort study. Ann Surg: 2016; 265 01 212 217
5. Gando S. Hayakawa M. Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost: 2016; 42 02 155 165
6. Brohi K. Cohen M. J. Davenport R. A. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care: 2007; 13 06 680 685
7. Holcomb J. B. Tilley B. C. Baraniuk S., et al. PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA: 2015; 313 05 471 482
8. Kashuk J. L. Moore E. E. Johnson J. L., et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma: packed red blood cells the answer? J Trauma: 2008; 65 02 261 270, discussion 270-271
9. Schöchl H. Nienaber U. Hofer G., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care: 2010; 14 02 R55
10. Theusinger O. M. Stein P. Spahn D. R. Applying 'Patient Blood Management' in the trauma center. Curr Opin Anaesthesiol: 2014; 27 02 225 232
11. Theusinger O. M. Stein P. Levy J. H. Point of care and factor concentrate-based coagulation algorithms. Transfus Med Hemother: 2015; 42 02 115 121
12. Haas T. Fries D. Tanaka K. A. Asmis L. Curry N. S. Schöchl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth: 2015; 114 02 217 224
13. Davenport R. Manson J. De'Ath H., et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med: 2011; 39 12 2652 2658
14. Schöchl H. Cotton B. Inaba K., et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care: 2011; 15 06 R265
15. Ponschab M. Voelckel W. Pavelka M. Schlimp C. J. Schöchl H. Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma. Scand J Trauma Resusc Emerg Med: 2015; 23 84
16. Theusinger O. M. Baulig W. Seifert B. Müller S. M. Mariotti S. Spahn D. R. Changes in coagulation in standard laboratory tests and ROTEM in trauma patients between on-scene and arrival in the emergency department. Anesth Analg: 2015; 120 03 627 635
17. Solomon C. Traintinger S. Ziegler B., et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost: 2011; 106 02 322 330
18. Bansal V. Fortlage D. Lee J. Doucet J. Potenza B. Coimbra R. A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma: 2011; 70 01 65 69, discussion 69-70
19. Spahn D. R. Spahn G. H. Stein P. Evidence base for restrictive transfusion triggers in high-risk patients. Transfus Med Hemother: 2015; 42 02 110 114
20. Park M. S. Martini W. Z. Dubick M. A., et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma: 2009; 67 02 266 275, discussion 275-276
21. Mann K. G. Butenas S. Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol: 2003; 23 01 17 25
22. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. Klin Wochenschr: 1948; 26 37/38 577 583
23. Luddington R. J. Thrombelastography/thromboelastometry. Clin Lab Haematol: 2005; 27 02 81 90
24. Sorensen B. Johansen P. Christiansen K. Woelke M. Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost: 2003; 1 03 551 558
25. Hvitfeldt Poulsen L. Christiansen K. Sorensen B. Ingerslev J. Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scand J Clin Lab Invest: 2006; 66 04 329 336
26. Rizoli S. Min A. Sanchez A. P., et al. In trauma, conventional ROTEM and TEG results are not interchangeable but are similar in clinical applicability. Mil Med: 2016; 181 (5, Suppl): 117 126
27. Sankarankutty A. Nascimento B. Teodoro da Luz L. Rizoli S. TEG® and ROTEM® in trauma: similar test but different results? World J Emerg Surg: 2012; 7 01 S3
28. Hagemo J. S. Næss P. A. Johansson P., et al. Evaluation of TEG(®) and RoTEM(®) inter-changeability in trauma patients. Injury: 2013; 44 05 600 605
29. Theusinger O. M. Nürnberg J. Asmis L. M. Seifert B. Spahn D. R. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg: 2010; 37 03 677 683
30. Theusinger O. M. Baulig W. Asmis L. M. Seifert B. Spahn D. R. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost: 2010; 104 02 385 391
31. Hiippala S. T. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis: 1995; 6 08 743 746
32. Moore H. B. Moore E. E. Gonzalez E., et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg: 2014; 77 06 811 817, discussion 817
33. Theusinger O. M. Wanner G. A. Emmert M. Y., et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg: 2011; 113 05 1003 1012
34. Chapman M. P. Moore E. E. Ramos C. R., et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg: 2013; 75 06 961 967, discussion 967
35. Harr J. N. Moore E. E. Ghasabyan A., et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock: 2013; 39 01 45 49
36. Roberts I. Shakur H. Afolabi A., et al. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet: 2011; 377 (9771): 1096 1101, 1101.e1-1101.e2
37. Morrison J. J. Dubose J. J. Rasmussen T. E. Midwinter M. J. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg: 2012; 147 02 113 119
38. Wafaisade A. Lefering R. Bouillon B. Böhmer A. B. Gäßler M. Ruppert M.; TraumaRegister DGU. Prehospital administration of tranexamic acid in trauma patients. Crit Care: 2016; 20 01 143
39. Schöchl H. Nienaber U. Maegele M., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care: 2011; 15 02 R83
40. Tauber H. Innerhofer P. Breitkopf R., et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study' Br J Anaesth: 2011; 107 03 378 387
41. Da Luz L. T. Nascimento B. Shankarakutty A. K. Rizoli S. Adhikari N. K. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care: 2014; 18 05 518
42. Gonzalez E. Moore E. E. Moore H. B., et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg: 2016; 263 06 1051 1059
43. Tapia N. M. Chang A. Norman M., et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg: 2013; 74 02 378 385, discussion 385-386
44. Casutt M. Konrad C. Schuepfer G. Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM™ Anaesthesist: 2012; 61 11 948 953
45. Nusa D. Harvey I. Almansouri A. Y., et al. Assessment of point-of-care measurement of international normalised ratio using the CoaguChek XS Plus system in the setting of acute ischaemic stroke. Intern Med J: 2013; 43 11 1205 1209
46. Beynon C. Jakobs M. Rizos T. Unterberg A. W. Sakowitz O. W. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients. Br J Neurosurg: 2014; 28 01 29 33
47. Beynon C. Unterberg A. W. Sakowitz O. W. Point of care coagulation testing in neurosurgery. J Clin Neurosci: 2015; 22 02 252 257
48. Cotte J. D'Aanda E. Chauvin V. Kaiser E. Meaudre E. Point-of-care coagulation testing for trauma patients in a military setting: a prospective study. J Spec Oper Med: 2013; 13 04 59 62
49. Niederdöckl J. Dempfle C. E. Schönherr H. R., et al. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors. Int J Lab Hematol: 2016; 38 04 426 434
50. Paniccia R. Priora R. Liotta A. A. Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag: 2015; 11 133 148
51. Duke W. W. The relation of blood platelets to hemorrhagic disease. By W.W. Duke. JAMA: 1983; 250 09 1201 1209
52. Jurk K. Analysis of platelet function and dysfunction. Hamostaseologie: 2015; 35 01 60 72
53. Franchini M. The platelet function analyzer (PFA-100): an update on its clinical use. Clin Lab: 2005; 51 07/08 367 372
54. Görlinger K. Dirkmann D. Hanke A. A., et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology: 2011; 115 06 1179 1191
55. Nekludov M. Bellander B-M. Blombäck M. Wallen H. N. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma: 2007; 24 11 1699 1706
56. Wohlauer M. V. Moore E. E. Thomas S., et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg: 2012; 214 05 739 746
57. Chowdhury M. Shore-Lesserson L. Mais A. M. Leyvi G. Thromboelastograph with Platelet Mapping(TM) predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth: 2014; 28 02 217 223
58. Carroll R. C. Chavez J. J. Snider C. C. Meyer D. S. Muenchen R. A. Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med: 2006; 147 04 197 204
59. Stissing T. Dridi N. P. Ostrowski S. R. Bochsen L. Johansson P. I. The influence of low platelet count on whole blood aggregometry assessed by Multiplate. Clin Appl Thromb Hemost: 2011; 17 06 E211 E217
60. Alström U. Granath F. Oldgren J. Ståhle E. Tydén H. Siegbahn A. Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. Thromb Res: 2009; 124 05 572 577
61. Naidech A. M. Jovanovic B. Liebling S., et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke: 2009; 40 07 2398 2401
62. Yu P-J. Cassiere H. A. Dellis S. L. Manetta F. Stein J. Hartman A. R. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting. J Card Surg: 2014; 29 03 312 316
63. Scharbert G. Auer A. Kozek-Langenecker S. Evaluation of the Platelet Mapping Assay on rotational thromboelastometry ROTEM. Platelets: 2009; 20 02 125 130
64. Grassetto A. Fullin G. Lazzari F., et al. Perioperative ROTEM and ROTEMplatelet monitoring in a case of Glanzmann's thrombasthenia. Blood Coagul Fibrinolysis: 2016; 28 01 96 99
65. Spahn D. R. Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth: 2005; 95 02 130 139
66. Toy P. Popovsky M. A. Abraham E., et al. National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med: 2005; 33 04 721 726
67. Holness L. Knippen M. A. Simmons L. Lachenbruch P. A. Fatalities caused by TRALI. Transfus Med Rev: 2004; 18 03 184 188
68. Theusinger O. M. Baulig W. Seifert B. Emmert M. Y. Spahn D. R. Asmis L. M. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth: 2011; 106 04 505 511
69. Spahn D. R. TEG®- or ROTEM®-based individualized goal-directed coagulation algorithms: don't wait - act now! Crit Care: 2014; 18 06 637
70. Hiippala S. T. Myllylä G. J. Vahtera E. M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg: 1995; 81 02 360 365
71. Martini W. Z. Chinkes D. L. Sondeen J. Dubick M. A. Effects of hemorrhage and lactated Ringer's resuscitation on coagulation and fibrinogen metabolism in swine. Shock: 2006; 26 04 396 401
72. Fries D. Martini W. Z. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth: 2010; 105 02 116 121
73. Nardi G. Agostini V. Rondinelli B., et al. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care: 2015; 19 83
74. Spahn D. R. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy. Thromb Res: 2012; 130 02 S15 S19
75. Kozek-Langenecker S. A. Afshari A. Albaladejo P., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol: 2013; 30 06 270 382
76. Theusinger O. M. Stein P. Spahn D. R. Transfusion strategy in multiple trauma patients. Curr Opin Crit Care: 2014; 20 06 646 655
77. Theusinger O. M. Spahn D. R. Ganter M. T. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol: 2009; 22 02 305 312
78. Sorensen B. Spahn D. R. Innerhofer P. Spannagl M. Rossaint R. Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity. Crit Care: 2011; 15 01 201
79. Goldstein J. N. Refaai M. A. Milling T. J. Jr., et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet: 2015; 385 (9982): 2077 2087
80. Pollack C. V. Jr. Reilly P. A. Eikelboom J., et al. Idarucizumab for dabigatran reversal. N Engl J Med: 2015; 373 06 511 520
81. Nystrup K. B. Windelov N. A. Thomsen A. B. Johansson P. I. Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality. Scand J Trauma Resusc Emerg Med: 2011; 19 52